Third-party data providers like IQVIA Digital and Crossix have long been the gold standard for DTC healthcare advertising measurement. The independent, clinical data tells pharma brands and their agencies if campaigns reached the right consumers, and creates the foundation of most campaign KPIs. A brand defines what performance looks like and third-party data confirms it.
But just having access to these gold standard metrics does not mean getting the most out of them. For years, the typical third-party measurement reporting process has created inefficiencies between what clients pay for and what they can act on in real time, but now that is changing.
This blog examines how third-party, direct-to-consumer advertising measurement in healthcare is evolving, where the gaps have been, and what a modern measurement solution built around the way campaigns actually run looks like.
How DTC Advertising Measurement with Third-Party Data Has Traditionally Worked
Providers like IQVIA and Crossix use cookies, tracking pixels, mobile ad IDs (MAIDs), and other identifiers to track consumer exposure, then match those identifiers against clinical data like diagnosis codes, prescription history, and treatment stage. That clinical matching is what makes third-party measurement in healthcare distinct from general digital measurement.
For a long time, receiving this read on performance, even after the campaign had already run, was considered sufficient. As DTC campaigns have become more sophisticated and agencies are held to higher performance standards, three gaps in that measurement have become harder to ignore.
- Timeliness. The largest gap is the lag in receiving this golden data. Agencies are expected to optimize against IQVIA and Crossix audience quality scores mid-flight. But under a traditional model, those scores arrive once or twice per year. By the time the data reaches the agency, the campaign has already concluded.
- Granular audience quality. Traditional measurement models deliver clinical validation at the campaign level. In niche therapeutic areas, where consumers are defined by specific diagnoses, treatment history, or disease stage, that lack of granularity is a real problem. Without tactic-level audience quality data, teams have no reliable signal on whether specific line items are reaching the audience they need to reach.
- Data visualization. When measurement reporting does arrive, it comes as data in Excel files. Agencies and brand teams are left to analyze that data themselves, adding time and friction.
What Evolving Third-Party DTC Advertising Measurement Looks Like
The next generation of third-party measurement in DTC healthcare closes all three of those inefficiencies.
- It gets more granular. Emerging tech is enabling clinical data validation at the campaign, line item, and tactic level, producing audience quality scores that reflect true in-target reach. That granularity makes it possible to identify where niche consumer audiences are and are not being reached, and to act on that information.
- It gets more timely. With integrations that PulsePoint is building, insights get delivered weekly and mid-flight so agencies can see which tactics are driving results and adjust targeting decisions while the campaign is still live.
- It gets more visual. Built-in dashboards that surface audience quality metrics, reach, conversion data, and performance trends in a clear, visual format, are ready for interpretation and decision-making without manual processing or cross-referencing across tools.
PulsePoint and IQVIA Digital’s Game-Changing Measurement Integration
PulsePoint is the first healthcare DSP to bring IQVIA Digital campaign measurement into the same place that ads are activated and run. IQVIA scores are surfaced at the campaign, line item, and tactic level. Plus, they are updated weekly, without requiring a separate report or a separate tool.
This is a genuine advantage for DTC healthcare advertising, and it directly addresses the timeliness and interoperability gaps that have long defined third-party measurement.
For existing IQVIA clients, this integration gives marketers more actionable access to the scores they already pay for. For non-IQVIA clients, it opens the door for a new way to access these validation measurements.
The metrics brands get with the PulsePoint IQVIA integration include:
- Audience Quality score
- Audience Quality Sample
- Target Reach Projected
- Consumer Reach Projected
- Number of New and Previously Exposed Consumers
- Gross NBRx Conversions
- Gross Office Visits
- Cost Per Target
- Average Frequency
- Total Spend
PulsePoint's Expanding DTC Measurement Ecosystem
IQVIA Insights is the first integration in PulsePoint's growing Measurement Ecosystem, in our platform’s aim to centralize clients' measurement partners alongside their activation workflow.
The ecosystem pairs IQVIA measurement data like audience quality data and office visits, with PulsePoint’s DTC Clinical Insights, which delivers near real-time clinical prescription activity. Together, these measurement solutions give agencies both the short-term signal needed for mid-flight optimization and the long-term proof needed to report campaign impact back to the brand.
That combination creates something genuinely new in DTC healthcare: a unified view of campaign performance that spans near real-time clinical signals and gold-standard audience quality scoring, all in one platform.
Improve DTC Ad Campaign Measurement with PulsePoint
DTC measurement data used to arrive too late, too raw, and too disconnected from the platforms where campaigns run. PulsePoint's growing measurement ecosystem changes that, setting a new standard for third-party measurement that validates consumer audience quality mid-flight, surfaces actionable insights visually, and sits alongside activation in a single platform built for the complexity of DTC healthcare.
Ready to see how PulsePoint's measurement ecosystem can level up your DTC campaigns? Contact us today to learn more.
.jpeg)
